by Brandon Tudor | Jun 3, 2026 | Blog
The article, “A therapeutic turning point in metabolic liver disease” (npj Gut and Liver, June 2026), is an editorial that argues the field of metabolic liver disease has entered a new era, driven by clearer disease definitions, deeper mechanistic understanding, and...
by Brandon Tudor | May 28, 2026 | Blog
Roche announced a new “Liver Disease Panel,” which it says is the first certified suite of digital algorithms designed to help clinicians detect and manage chronic liver disease (CLD) earlier and more efficiently. Key points from the announcement: The panel focuses...
by Brandon Tudor | May 17, 2026 | Blog
This May 16, 2026 Cureus review titled “Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Diagnostic Pathways, Noninvasive Fibrosis Assessment, and Therapeutic Strategies” is essentially a “state of the field” overview of MASLD (formerly...
by Brandon Tudor | May 8, 2026 | Blog
This paper titled “Organ failure-based clinical classification at onset of acute-on-chronic liver failure: a prospective multicenter cohort study” from Scientific Reports proposes a new way to classify acute-on-chronic liver failure (ACLF) based on which...
by Brandon Tudor | Apr 30, 2026 | Blog
Summary of the article from Pitchbook titled “PitchBook Analyst Note: AI Will Deliver Care to Billions and Break the System That Built It.” 🧠 Core thesis AI will massively expand access to healthcare (to “billions”)—but in doing so, it will fundamentally...
